Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $69.89, with a ...
Rhythm Pharmaceuticals (RYTM) and the Raymond A. Wood Foundation announced a new research collaboration to study the impact of fatigue on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback